Using the Golden Triangle to optimize clearance and oral absorption

Lipinski, 2004, Drug Discovery Today, 1, 337, 10.1016/j.ddtec.2004.11.007 Lipinski, 1997, Adv. Drug Delivery Rev., 23, 3, 10.1016/S0169-409X(96)00423-1 Bhal, 2007, Mol. Pharm., 4, 556, 10.1021/mp0700209 Veber, 2002, J. Med. Chem., 45, 2615, 10.1021/jm020017n Waring, 2009, Bioorg. Med. Chem. Lett., 19, 2844, 10.1016/j.bmcl.2009.03.109 Leeson, 2007, Nat. Rev., 6, 881 Hughes, 2008, Bioorg. Med. Chem. Lett., 18, 4872, 10.1016/j.bmcl.2008.07.071 Wenlock, 2003, J. Med. Chem., 46, 1250, 10.1021/jm021053p Bickett, 1993, Trends Pharmacol. Sci., 14, 292, 10.1016/0165-6147(93)90043-J Obach, 2001, Curr. Opin. Drug Discovery Dev., 4, 36 Shah, 2006, Biotechnol. Prog., 22, 186, 10.1021/bp050208u Artursson, 2001, Adv. Drug Deliv. Rev., 46, 27, 10.1016/S0169-409X(00)00128-9 Yee, 1997, Pharm. Res., 14, 763, 10.1023/A:1012102522787 Hitzel, 2000, Pharm. Res., 17, 1389, 10.1023/A:1007546905874 Gulyaeva, 2002, Eur. J. Pharm. Sci., 17, 81, 10.1016/S0928-0987(02)00146-X Lombardo, 2001, J. Med. Chem., 44, 2490, 10.1021/jm0100990 Valko, 2001, Curr. Med. Chem., 8, 1137, 10.2174/0929867013372643 Camenisch, 1998, Eur. J. Pharm. Sci., 6, 325 Gleeson, 2008, J. Med. Chem., 51, 817, 10.1021/jm701122q Zhang, 2002, Adv. Drug Delivery Rev., 54, 329, 10.1016/S0169-409X(02)00007-8 Seelig, 1998, Eur. J. Biochem. FEBS, 251, 252, 10.1046/j.1432-1327.1998.2510252.x Szakacs, 2006, Nat. Rev., 5, 219 Hitchcock, 2006, J. Med. Chem., 49, 7559, 10.1021/jm060642i Reynolds, 2008, J. Med. Chem., 51, 2432, 10.1021/jm701255b Lewis, 2009, J. Comput. Aided Mol. Des., 23, 97, 10.1007/s10822-008-9242-3